CollaneX Therapeutics: working on a breakthrough in the fight against fibrosis
Fibrosis is the excessive formation of connective tissue in an organ or tissue; it is known from scars, but it can also occur in the liver as a result of obesity. An unhealthy lifestyle causes liver fibrosis to increase to such an extent that the disease almost begins to take on epidemic proportions, and no medicine is yet available. TNO has built up unique knowledge over the past decade that it wants to co-develop further with market parties into an effective medicine. This is currently being done by the newly founded CollaneX Therapeutics, a spin-off company of TNO. This biotech company will develop medicines against fibrosis, initially during the first phase of development independently, later in collaboration with pharmaceutical companies.
Working on a breakthrough in the fight against fibrosis
Fibrosis is the excessive formation of connective tissue in an organ or tissue; it is known from scars, but it can also occur in the liver as a result of obesity. An unhealthy lifestyle causes liver fibrosis to increase to such an extent that the disease almost begins to take on epidemic proportions, and no medicine is yet available. TNO has built up unique knowledge over the past decade that it wants to co-develop further with market parties into an effective medicine.
This is currently being done by the newly founded CollaneX Therapeutics, a spin-off company of TNO. This biotech company will develop medicines against fibrosis, initially during the first phase of development independently, later in collaboration with pharmaceutical companies.
Number of patients growing
Efforts to develop anti-fibrosis medicines are happening worldwide. Fibrosis can occur in many organs, such as the heart, lungs, liver and kidneys, and the number of patients with liver fibrosis is rising sharply. In the US alone 130 million people are affected by obesity, which in many cases leads to liver disorders and consequently an increase in the number of liver transplants as a result of fibrosis.
Why from TNO?
As a TNO spin-off, CollaneX has unique knowledge of both the disease and the pharmaceutical market. The scientists forming the company have developed numerous models that provide insight into the mechanisms of the disease as well as identified a unique target that helps to develop a medicine with potentially few side effects. The unique combination of knowledge of mechanisms, models and the market has convinced CollaneX that it can make a breakthrough in the fight against fibrosis.
Contact us
-
Susanna Rademaekers
Functie:Tech Transfer Support-
Standplaats:Den Haag - New Babylon
-
Telefoon:+31 6 15 93 16 57
-
Email:Email Susanna
-
LinkedIn:Susanna on LinkedIn
-
Get inspired
TNO studies on geothermal energy potential find their way to art gallery in Turin
You’re working at TNO on long-term scenarios for the energy system to meet global climate targets by 2050 and suddenly you receive an email from a famous Italian photographer. ‘Can our visual designer turn this into something beautiful?’
ENGAGE: Patient-driven technology for better insight into disease
The newly formed ENGAGE consortium brings together partners from the entire healthcare ecosystem to develop and implement technological solutions that help people with Type 2 Diabetes address meaningful aspects of their health.
Time setters: The future of military land operations with MICE and HUVIX simulators
At TNO, we make a mark on our time. In this series, you’ll meet the TNO employees behind the innovations – the time setters. What do they do exactly and what impact does their work have on society? In this episode, we talk to time setter Maarten Michel, an interaction design researcher at Human Machine Teaming in Soesterberg, about how military personnel can perform optimally on land using the HUVIX and the MICE.
Supporting municipalities to achieve heat transition
Local governments, especially municipalities, play a crucial role in the heat transition. Over 90 per cent of homes in the Netherlands are currently heated using fossil fuel, mainly natural gas. Find out how TNO supports municipalities with knowledge, experience and tools for sustainable heat sources like geothermal.
AI makes geothermal energy more efficient and productive
TNO has shown in the geothermal sector that much more insight can be gained from available data using AI to improve processes and even predict possible disruptions. Image: RCSG / Floris Scheplitz
